Trump’s Environmental Policies Could Threaten the Progress of Blue Economy ETFs
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 20 2024
0mins
Source: TipRanks
Impact of Trump's Policies on Blue Economy ETFs: Donald Trump's potential return to the White House and his plans to roll back pro-climate regulations could negatively affect blue economy exchange-traded funds (ETFs), particularly those focused on ocean-related companies. The KraneShares Rockefeller Ocean Engagement ETF (KSEA) is expected to be more resilient compared to others like IQ Clean Oceans ETF (OCEN) and Global X CleanTech ETF (CTEC).
Performance Outlook for KSEA: Analysts have a Moderate Buy consensus rating on KSEA, with strong performance indicators suggesting it can withstand unfavorable market conditions. The fund has shown a 12% rally over the past year, with an average price target indicating further upside potential.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WM
Wall Street analysts forecast WM stock price to rise
20 Analyst Rating
15 Buy
5 Hold
0 Sell
Strong Buy
Current: 218.790
Low
223.00
Averages
247.61
High
266.00
Current: 218.790
Low
223.00
Averages
247.61
High
266.00
About WM
Waste Management, Inc. is a provider of environmental solutions. The Company provides collection, recycling, and disposal services to millions of residential, commercial, industrial, and municipal customers throughout the United States and Canada. Its segments include East Tier, West Tier, Recycling Processing and Sales, WM Renewable Energy, and WM Healthcare Solutions. East Tier primarily consists of geographic areas located in the Eastern U.S., the Great Lakes region and all of Canada. The West Tier primarily includes geographic areas located in the Western U.S., including the upper Midwest region and British Columbia, Canada. Recycling Processing and Sales includes the processing and sales of materials collected from residential, commercial, and industrial customers. WM Renewable Energy develops, operates, and promotes projects for the beneficial use of landfill gas. WM Healthcare Solutions includes Regulated Waste and Compliance Services and Secure Information Destruction services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Bill Gates Foundation Sells Microsoft Shares, Invests in West Pharmaceutical Services
- Gates Foundation Sells Microsoft: Bill Gates has gradually sold off his Microsoft shares over 25 years, completing the final sale in Q1 2023, which may impact the stability of his investment portfolio as he exits a major tech position.
- New Investment Emerges: The foundation initiated a position in West Pharmaceutical Services last quarter, a leading manufacturer of injectable drug delivery systems, indicating confidence in its potential to become a future Dividend King, reflecting a strategic shift in investment focus.
- Earnings Growth Forecast: West Pharmaceutical is projected to report earnings per share (EPS) of $8.62 and $9.55 in 2026 and 2027, respectively, representing a 14% to 15% growth compared to the forecast EPS of $7.29 for 2025, showcasing its resilience in a recession-resistant industry.
- Dividend Growth Potential: Although the current dividend yield is under 0.3%, West has increased its dividend for 32 consecutive years, suggesting that strong earnings growth and a potential resurgence in dividend growth could yield significant total returns for both dividend and growth investors in the long run.
See More
Gates Foundation Trust Sells Off Microsoft Stock
- Microsoft Exit: The Gates Foundation Trust completed its final sale of Microsoft stock in Q1 2023, marking the end of a long-term investment in the tech giant and indicating a strategic shift in asset allocation.
- New Investment: The foundation added West Pharmaceutical Services to its $31 billion portfolio, a lesser-known healthcare stock that presents promising dividend growth potential, appealing to long-term investors seeking stability.
- Earnings Growth Forecast: West Pharmaceutical is projected to achieve earnings per share of $8.62 and $9.55 in 2026 and 2027, respectively, reflecting a 14% to 15% growth from the 2025 forecast of $7.29, suggesting a potential earnings growth surge ahead.
- Dividend Growth Potential: Although West's current forward dividend yield is under 0.3%, its 32-year history of increasing dividends indicates strong return potential, with future earnings growth likely to enhance dividend payouts significantly.
See More
Analysis of Bill Gates Foundation's Investment Portfolio
- Portfolio Overview: The Gates Foundation Trust manages over $31.6 billion in assets, with 63% allocated to three large-cap stocks, indicating a preference for stable returns amidst market volatility.
- Berkshire Hathaway: 26% of the trust's investments are in Berkshire Hathaway, a company with a market cap exceeding $1 trillion, providing robust financial support to the foundation through its diversified operations and consistent cash flow generation.
- Waste Management: 20% of the trust is invested in Waste Management, which not only maintains a strong position in waste collection but also shows growth potential in renewable energy and healthcare waste disposal, despite its stock performance being lackluster.
- Canadian National Railway: The trust holds 17% in Canadian National Railway, which, while facing economic challenges and stock underperformance, retains a strong transportation network and a relatively low debt ratio, offering some defensive qualities within the investment portfolio.
See More
Investment Overview of Bill & Melinda Gates Foundation
- Foundation Donations: Since 2000, the Gates Foundation has donated approximately $8.5 billion to 1,472 grantees, highlighting its significant impact on global philanthropy, although its investment decisions are managed separately from charitable activities.
- Portfolio Structure: As of the first quarter, the Gates Foundation Trust had over $31.6 billion in assets, with 63% invested in just three large-cap stocks, reflecting a preference for stable and mature companies, particularly Berkshire Hathaway.
- Role of Berkshire Hathaway: As the largest stock in the portfolio, Berkshire Hathaway boasts a market cap exceeding $1 trillion, showcasing its advantages in wealth preservation and growth, despite not growing as rapidly as pure-play AI companies.
- Challenges for Canadian National Railway: With 17% of the Gates Trust's investments in Canadian National Railway, which transports over $181 billion in goods annually, the stock has struggled due to trade tensions and economic downturns, yielding only a 1.5% gain over the past five years.
See More
Bill Gates Foundation Investment Insights
- Wealth Donation Plan: Bill Gates plans to donate nearly all of his wealth over the next 20 years, with the foundation expected to spend over $200 billion during this period, reflecting his ongoing commitment to combat global poverty and disease.
- Portfolio Structure: The Gates Foundation trust fund is primarily composed of value stocks, with Microsoft remaining a significant holding; despite recent share sales, Gates retains approximately $43 billion in Microsoft stock.
- Berkshire Hathaway Holdings: The foundation's largest position is in Berkshire Hathaway Class B shares, which account for 25% of the portfolio, bolstered by Warren Buffett's annual donations, ensuring a steady influx of funds for the foundation.
- WM Company Performance: WM, the second-largest holding in the foundation's portfolio at 18%, benefits from its strong market position and sustainable business initiatives, leading to margin improvements despite challenges posed by climate change.
See More
Gates Foundation Shifts Focus to Value Stocks
- Investment Strategy Shift: The Gates Foundation's investment managers are favoring value stocks over growth stocks, with two primary value stocks trading around fair value, indicating a preference for stable returns that may enhance the fund's long-term financial stability.
- Microsoft Share Donation Plan: Gates plans to donate nearly all of his Microsoft shares over the next 20 years, currently holding 103 million shares worth about $43 billion, which will reduce the fund's reliance on Microsoft while providing more capital to support its philanthropic mission.
- Berkshire Hathaway's Continued Investment: Berkshire Hathaway Class B shares account for about 25% of the fund's portfolio, benefiting from Warren Buffett's annual donations; despite high spending requirements, the fund has managed to retain a significant number of shares, reflecting a strong commitment to value investing.
- WM's Market Position: WM, formerly Waste Management, constitutes about 18% of the fund, leveraging its 262 active landfills and strong scale advantages, with EBITDA margins reaching 29.8% last quarter, showcasing growth potential in sustainable energy and medical waste, although its current P/E ratio of nearly 27 suggests a premium price for its competitive advantages.
See More
Bill Gates Foundation Sells Microsoft Shares, Invests in West Pharmaceutical Services
- Gates Foundation Sells Microsoft: Bill Gates has gradually sold off his Microsoft shares over 25 years, completing the final sale in Q1 2023, which may impact the stability of his investment portfolio as he exits a major tech position.
- New Investment Emerges: The foundation initiated a position in West Pharmaceutical Services last quarter, a leading manufacturer of injectable drug delivery systems, indicating confidence in its potential to become a future Dividend King, reflecting a strategic shift in investment focus.
- Earnings Growth Forecast: West Pharmaceutical is projected to report earnings per share (EPS) of $8.62 and $9.55 in 2026 and 2027, respectively, representing a 14% to 15% growth compared to the forecast EPS of $7.29 for 2025, showcasing its resilience in a recession-resistant industry.
- Dividend Growth Potential: Although the current dividend yield is under 0.3%, West has increased its dividend for 32 consecutive years, suggesting that strong earnings growth and a potential resurgence in dividend growth could yield significant total returns for both dividend and growth investors in the long run.
See More
Gates Foundation Trust Sells Off Microsoft Stock
- Microsoft Exit: The Gates Foundation Trust completed its final sale of Microsoft stock in Q1 2023, marking the end of a long-term investment in the tech giant and indicating a strategic shift in asset allocation.
- New Investment: The foundation added West Pharmaceutical Services to its $31 billion portfolio, a lesser-known healthcare stock that presents promising dividend growth potential, appealing to long-term investors seeking stability.
- Earnings Growth Forecast: West Pharmaceutical is projected to achieve earnings per share of $8.62 and $9.55 in 2026 and 2027, respectively, reflecting a 14% to 15% growth from the 2025 forecast of $7.29, suggesting a potential earnings growth surge ahead.
- Dividend Growth Potential: Although West's current forward dividend yield is under 0.3%, its 32-year history of increasing dividends indicates strong return potential, with future earnings growth likely to enhance dividend payouts significantly.
See More
Analysis of Bill Gates Foundation's Investment Portfolio
- Portfolio Overview: The Gates Foundation Trust manages over $31.6 billion in assets, with 63% allocated to three large-cap stocks, indicating a preference for stable returns amidst market volatility.
- Berkshire Hathaway: 26% of the trust's investments are in Berkshire Hathaway, a company with a market cap exceeding $1 trillion, providing robust financial support to the foundation through its diversified operations and consistent cash flow generation.
- Waste Management: 20% of the trust is invested in Waste Management, which not only maintains a strong position in waste collection but also shows growth potential in renewable energy and healthcare waste disposal, despite its stock performance being lackluster.
- Canadian National Railway: The trust holds 17% in Canadian National Railway, which, while facing economic challenges and stock underperformance, retains a strong transportation network and a relatively low debt ratio, offering some defensive qualities within the investment portfolio.
See More
Investment Overview of Bill & Melinda Gates Foundation
- Foundation Donations: Since 2000, the Gates Foundation has donated approximately $8.5 billion to 1,472 grantees, highlighting its significant impact on global philanthropy, although its investment decisions are managed separately from charitable activities.
- Portfolio Structure: As of the first quarter, the Gates Foundation Trust had over $31.6 billion in assets, with 63% invested in just three large-cap stocks, reflecting a preference for stable and mature companies, particularly Berkshire Hathaway.
- Role of Berkshire Hathaway: As the largest stock in the portfolio, Berkshire Hathaway boasts a market cap exceeding $1 trillion, showcasing its advantages in wealth preservation and growth, despite not growing as rapidly as pure-play AI companies.
- Challenges for Canadian National Railway: With 17% of the Gates Trust's investments in Canadian National Railway, which transports over $181 billion in goods annually, the stock has struggled due to trade tensions and economic downturns, yielding only a 1.5% gain over the past five years.
See More
Bill Gates Foundation Investment Insights
- Wealth Donation Plan: Bill Gates plans to donate nearly all of his wealth over the next 20 years, with the foundation expected to spend over $200 billion during this period, reflecting his ongoing commitment to combat global poverty and disease.
- Portfolio Structure: The Gates Foundation trust fund is primarily composed of value stocks, with Microsoft remaining a significant holding; despite recent share sales, Gates retains approximately $43 billion in Microsoft stock.
- Berkshire Hathaway Holdings: The foundation's largest position is in Berkshire Hathaway Class B shares, which account for 25% of the portfolio, bolstered by Warren Buffett's annual donations, ensuring a steady influx of funds for the foundation.
- WM Company Performance: WM, the second-largest holding in the foundation's portfolio at 18%, benefits from its strong market position and sustainable business initiatives, leading to margin improvements despite challenges posed by climate change.
See More
Gates Foundation Shifts Focus to Value Stocks
- Investment Strategy Shift: The Gates Foundation's investment managers are favoring value stocks over growth stocks, with two primary value stocks trading around fair value, indicating a preference for stable returns that may enhance the fund's long-term financial stability.
- Microsoft Share Donation Plan: Gates plans to donate nearly all of his Microsoft shares over the next 20 years, currently holding 103 million shares worth about $43 billion, which will reduce the fund's reliance on Microsoft while providing more capital to support its philanthropic mission.
- Berkshire Hathaway's Continued Investment: Berkshire Hathaway Class B shares account for about 25% of the fund's portfolio, benefiting from Warren Buffett's annual donations; despite high spending requirements, the fund has managed to retain a significant number of shares, reflecting a strong commitment to value investing.
- WM's Market Position: WM, formerly Waste Management, constitutes about 18% of the fund, leveraging its 262 active landfills and strong scale advantages, with EBITDA margins reaching 29.8% last quarter, showcasing growth potential in sustainable energy and medical waste, although its current P/E ratio of nearly 27 suggests a premium price for its competitive advantages.
See More
